Salivary gland fine‐needle aspiration cytology (FNAC) is a valuable tool for diagnosing and managing salivary gland tumors, offering a minimally invasive and precise method. However, challenges such as tumor heterogeneity and morphological similarities between benign and malignant lesions exist. The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) was developed to standardize reporting terminologies and risk assessment. A prospective study was conducted on 100 cases of salivary gland lesions, categorizing them based on the MSRSGC. Histopathological correlations were performed where available and diagnostic accuracy metrics were calculated. The majority of cases were in the 21‐40 age group, predominantly affecting the parotid gland. Cytological‐histopathological correlation showed variable accuracy across different lesion types. The diagnostic accuracy of FNAC was 87.00%, with sensitivity and specificity at 65.22% and 93.5% respectively. The risk of malignancy varied across MSRSGC categories, with the AUS category presenting a 100% risk. Pleomorphic adenoma was the most prevalent lesion, with notable misdiagnoses observed. The MSRSGC provides valuable risk stratification for salivary gland lesions, aiding in treatment decisions and patient counseling. Despite challenges, FNAC remains effective in distinguishing between benign and malignant lesions, demonstrating comparable diagnostic accuracy to previous studies. Standardized reporting systems like the MSRSGC contribute to improved consistency and reliability in diagnosing salivary gland lesions.
Parul Maheshwari and Deepak Parmar. Assessment of Risk of Malignancy by Application of Milan System of Reporting Salivary Gland Cytopathology.
DOI: https://doi.org/10.36478/10.59218/makrjms.2024.4.424.429
URL: https://www.makhillpublications.co/view-article/1815-9346/10.59218/makrjms.2024.4.424.429